BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 178234)

  • 21. [Possible applications of living BCG and the BCG cell wall in immunotherapy].
    Canti GF; Franco P; Ricci L
    Boll Ist Sieroter Milan; 1983 May; 62(2):125-9. PubMed ID: 6626318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
    McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
    Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of melanoma.
    Nathanson L
    J Cutan Pathol; 1979 Jun; 6(3):213-26. PubMed ID: 383755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of malignant melanoma.
    Rosenberg SA
    Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intralymphatic administration of BCG-CWS in advanced malignant melanoma].
    Mannami T; Matsumi A; Ichikawa J; Kagawa S; Orita K; Motoi M
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):85-90. PubMed ID: 7184364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.
    Morton DL; Eilber FR; Holmes EC; Sparks FC; Ramming K
    Med Clin North Am; 1976 May; 60(3):431-9. PubMed ID: 1271888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of malignant melanoma.
    Terry WD
    N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
    Mulé JJ; Ettinghausen SE; Spiess PJ; Shu S; Rosenberg SA
    Cancer Res; 1986 Feb; 46(2):676-83. PubMed ID: 3484431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
    Mastrangelo MJ; Bellet RE; Berkelhammer J; Clark WH
    Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
    Spitler LE; Wong P; Sagebiel R
    Arch Dermatol; 1978 Oct; 114(10):1501-4. PubMed ID: 718187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T
    Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunotherapy for malignant disease.
    Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
    [No Abstract]   [Full Text] [Related]  

  • 35. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
    Ariyan S; Kirkwood JM; Mitchell MS; Nordlund JJ; Lerner AB; Papac RJ
    Surgery; 1982 Sep; 92(3):459-63. PubMed ID: 7112396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
    Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
    Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of cancer: current status.
    Goodnight JE; Morton DL
    Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunotherapy in bronchial carcinoma].
    Havemann K
    Onkologie; 1980 Jun; 3(3):120-6. PubMed ID: 6258119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A Southwest Oncology Group study.
    McCracken JD; Heilbrun L; White J; Reed R; Samson M; Saiers JH; Stephens R; Stuckey WJ; Bickers J; Livingston R
    Cancer; 1980 Dec; 46(11):2335-40. PubMed ID: 6254629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacillus Calmette-Guérin contact immunotherapy of local and metastatic deposits of rat tumors.
    Baldwin RW; Hopper DG; Pimm MV
    Ann N Y Acad Sci; 1976; 277(00):124-34. PubMed ID: 1069545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.